Botulinum Toxin: A Global Strategic Business Report
San Jose, California (PRWEB) September 22, 2014
Follow us on LinkedIn – The primal desire to stay young has groomed and nurtured anti-aging products and technologies into a multi-billion dollar industry worldwide. Growing emphasis on appearance maintenance is benefitting the market for botulinum toxin. Botulinum Toxin is a neurotoxic protein obtained from the bacterium, Clostridium Botulinum, which arrests the release of acetylcholine, resulting in muscle relaxation. With cosmetic indications for botulinum toxin ranging from facial wrinkles to eyebrow furrows, the rapidly aging world population emerges as a strong demographic driver of growth. Increasing demand for minimally-invasive cosmetic procedures and growing affluence of consumers in emerging markets also augurs well for market growth. In addition, expanding medical application of botulinum toxin with recent product approvals for new neuromuscular indications is helping drive demand in the market.
Cosmetic botulinum toxin injection is essentially an elective treatment where demand is strongly dictated by socio-economic conditions and economic status of target demographic clusters. Ease of treatment, increased access to local therapy service providers, and availability of treatment options at affordable price points continue to push botulinum toxin into the mainstream aesthetic treatment market. Future growth in the therapeutic botulinum toxin market will be driven by the increasing focus on research and development of new treatment indications. Strengthening product pipeline and growing off-label use provide a strong long-term outlook for the market.
As stated by the new market research report on Botulinum Toxin, the United States represents the largest market worldwide. The country’s dominance is supported by the increasing number of approvals of Botox and other BTX products for use in new therapeutic and cosmetic indications. Asia-Pacific ranks as the fastest growing market with a projected CAGR of 14.9% over the analysis period. Primary growth drivers in the region include rapidly improving socio-economic conditions, strong economic growth and increasing aesthetic awareness among the populace.
Key players covered in the report include Allergan Inc., Ipsen Group, Medy-Tox Incorporated, Mentor Corporation, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics Inc., and US WorldMeds, among others.
The research report titled “Botulinum Toxin: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of major companies worldwide. The report provides market estimates and projections in US dollars for all major geographic markets including the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Application segments analyzed include Cosmetic and Therapeutic.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/